Approval · Notice of Compliance 4670 · 1996
SAIZEN: Notice of Compliance 4670
Issued November 29, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4670
- Date
- November 29, 1996
- Company
- Serono Canada Inc.
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Changes to manufacturing
- Therapeutic class
- Human growth hormone - growth stimulant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SAIZEN | 02215136 | Cancelled Post Market |
Medicinal ingredients
- SOMATROPIN 10 UNIT per VIAL